Prognostic nutritional index (PNI) and Controlling Nutritional Status (CONUT) are two model that incorporates the role of inflammation and nutrition factors to predict the progression of tumor. The primary objective of this investigation is to examine the ability of PNI and CONUT score for predicting the survival in breast cancer patients. A comprehensive search was conducted on the Cochrane Library, Scopus, Europe PMC, and Medline databases up until August 14th, 2023, utilizing a combination of relevant keywords. This review incorporates literature that examines the relationship between PNI, CONUT, and survival in breast cancer. We employed random-effect models to analyze the hazard ratio (HR) and present the outcomes together with their corresponding 95 % confidence intervals (CI). A total of sixteen studies were incorporated. The results of our meta-analysis indicated that high PNI was associated with better overall survival (OS) (HR 0.38; 95%CI: 0.28–0.51, p < 0.00001, I2 = 32 %), but not disease-free survival (DFS) (HR 0.60; 95%CI: 0.33–1.10, p = 0.10, I2 = 78 %) than low PNI in breast cancer patients. Meta-analysis also indicated that high CONUT was associated with worse OS (HR 1.66; 95%CI: 1.21–2.28, p = 0.002, I2 = 78 %) and worse DFS (HR 2.09; 95%CI: 1.60–2.73, p < 0.00001, I2 = 41 %) in breast cancer patients. This study suggests the prognostic role of both PNI and CONUT score for predicting survival in breast cancer patients.
Available evidence has unequivocally established the significance of inflammation in the onset and advancement of cancer. Pan-immune-inflammation value (PIV) is an evaluation method that incorporates the role of different white blood cells (WBC) subsets to predict the progression of cancer. The main aim of this study is to assess the feasibility of the PIV score in predicting prognosis among women with breast cancer. A thorough search was performed on the Scopus, Europe PMC, Cochrane Library, and Medline databases up until September 25th, 2024, employing a combination of pertinent keywords. This investigation includes paper that explores the connection of PIV and survival in breast neoplasm. We utilized random-effects models to assess the hazard ratio (HR) and report the results together with their respective 95% confidence intervals (CI). Sixteen papers were chosen for analysis. The findings of our meta-analysis from multivariate data indicated that breast cancer patients who possessed high PIV score had a higher risk of shorter overall survival (OS) (HR 2.22; 95% CI 1.60–3.07, p < 0.00001, I2 = 55%), poorer progression-free survival (PFS) (HR 1.58; 95% CI 1.16–2.15, p = 0.003, I2 = 53%), and lower likelihood of achieving pathological complete response (pCR) (HR 0.45; 95% CI 0.27–0.75, p = 0.002, I2 = 47%) than those with low PIV score. The present review indicates the prognostic ability of PIV score in forecasting the prognosis of breast cancer patients.
20 February 2018 in GATR Accounting and Finance Review
Objective - This study aims to examine and explain the relationship between a company's internal factors such as profitability, solvency and audit committee, and external factors including complexity and size of public accounting firms, with audit delay. Methodology/Technique - The importance of financial information is, in part, due to its utility for assessment of company performance. Hence, financial information should be produced and reported as quickly as possible each year. Findings - This study finds that manufacturing companies with high debt levels and low profitability experience longer audit delay. Moreover, the results in this study show that debt level is the most influential and significant factor with a positive relationship to audit delay. Novelty - This study shows that profitability, the number of members on an audit committees and public accounting firm (KAP) size all have an insignificant negative relationship with audit delay. Further, complexity has an insignificant positive relationship with audit delay. Type of Paper: Empirical Keywords: Profitability; Debt; Complexity; Audit Committees; Audit Delays. JEL Classification: M42, M41.
A male in his 60s presented with a four-month history of dysuria and lower urinary tract symptoms (LUTS). He had a history of elevated PSA and benign prostatic hyperplasia (BPH), previously treated with transurethral resection of the prostate (TURP). Multiparametric MRI (MP-MRI) revealed a PI-RADS 5 lesion, raising suspicion of malignancy. However, histopathological analysis from MRI fusion-targeted biopsies confirmed tuberculous prostatitis. The patient was treated with antituberculosis drugs, resulting in symptomatic improvement and a significant PSA decline. This case highlights the diagnostic challenge of distinguishing tuberculous prostatitis from prostate cancer, particularly in tuberculosis-endemic regions. Our literature review reveals that patients with tuberculous prostatitis undergoing MRI are at least 50 years old, originate from endemic areas, and exhibit PI-RADS scores ranging from 2 to 5, indicating inter-rater variability. Histopathological confirmation remains essential in cases with ambiguous imaging and clinical findings.
Background: A glioma is a form of tumor that is abundant in blood vessels. Vascular endothelial growth factor receptor (VEGFR) and its receptor 2 (VEGFR2) are important in the process of angiogenesis. The relationship between VEGFR2 rs2071559 and glioma development is currently uncertain. The present study aims to analyze the correlation between VEGFR2 rs2071559 gene polymorphism and the susceptibility to gliomas. Methods: A thorough search was carried out in the Cochrane Library, Scopus, and Medline databases from inception until 20 February 2024 using a mix of pertinent keywords. We used random-effects models to examine the odds ratio (OR) and reported the results together with their respective 95% confidence intervals (CIs). Results: A total of six studies were incorporated. The results of our meta-analysis indicated that all genetic models of VEGFR2 rs2071559 gene polymorphism, starting from dominant (OR 1.40; p < 0.00001), recessive (OR 1.52; p < 0.0001), CC genotype (OR 1.78; p < 0.00001), CT genotype (OR 1.30; p < 0.0001), and C allele (OR 1.41; p < 0.00001), were associated with a higher risk of developing gliomas. The subgroup analysis revealed a higher OR for studies with a sample size of ≥500, originated from Asia, with a mean age of ≥42.3 years, and a male prevalence of <57%. Conclusions: This study suggests that VEGFR2 rs2071559 gene polymorphism is associated with a higher risk of gliomas.
28 December 2020 in Ultima Accounting : Jurnal Ilmu Akuntansi
The purpose of this research is to investigate the association between firm size using Ln total asset, asset funding using Debt to Total Asset (DAR) and asset composition, and also profitability using Return on Asset (ROA) on tax aggressiveness using Effective Tax Rate (ETR). Sample in this research were manufacturing public company which listed consecutively during period 2016-2018. The others criteria were publishing audited financial statement, using Rupiah as reporting currency, have same reporting period which ended at December 31, positively profit and also have assets value within 1 up to 4 trillion. Data analysis method used multiple regression. The result of this research found that only asset funding (DAR) has significant positive effect towards tax aggressiveness (ETR) while firm size, profitability (ROA) and asset composition (CAIR) has no effect on tax aggressiveness (ETR. Keywords: Capital Intensity, Firm Size, Leverage, Profitability, Tax Aggressiveness.